Atara Biotherapeutics, Inc. (LON:0HIY)
London · Delayed Price · Currency is GBP · Price in USD 4.835
+0.205 (4.43%)
Feb 6, 2026, 5:04 PM GMT
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of 25.85 million as of February 6, 2026. Its market cap has decreased by -19.76% in one year.
Market Cap
25.85M
Enterprise Value
28.24M
Revenue
113.03M
Ranking
n/a
PE Ratio
1.49
Stock Price
4.84
Market Cap Chart
Since October 17, 2014, Atara Biotherapeutics's market cap has decreased from 144.86M to 25.85M, a decrease of -82.15%. That is a compound annual growth rate of -14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 24.02M | -75.22% |
| Dec 31, 2025 | 96.91M | 58.26% |
| Dec 31, 2024 | 61.24M | 49.24% |
| Dec 29, 2023 | 41.03M | -84.11% |
| Dec 30, 2022 | 258.28M | -74.90% |
| Dec 31, 2021 | 1.03B | -13.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.82B |
| GSK plc | 87.48B |
| Haleon | 35.56B |
| Smith & Nephew | 10.99B |
| Arecor Therapeutics | 29.26M |
| Provexis | 28.85M |
| Abingdon Health | 26.00M |
| Aptamer Group | 25.62M |